U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C16H19N3S
Molecular Weight 285.407
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ISOTHIPENDYL

SMILES

CC(CN1C2=C(SC3=C1N=CC=C3)C=CC=C2)N(C)C

InChI

InChIKey=OQJBSDFFQWMKBQ-UHFFFAOYSA-N
InChI=1S/C16H19N3S/c1-12(18(2)3)11-19-13-7-4-5-8-14(13)20-15-9-6-10-17-16(15)19/h4-10,12H,11H2,1-3H3

HIDE SMILES / InChI

Molecular Formula C16H19N3S
Molecular Weight 285.407
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Description
Curator's Comment: description was created based on several sources, including https://www.drugs.com/international/isothipendyl.html | https://www.ncbi.nlm.nih.gov/pubmed/22677929 | https://www.ncbi.nlm.nih.gov/pubmed/13792589 | https://www.ncbi.nlm.nih.gov/pubmed/14157559

Isothipendyl is a first generation H1 antagonist (antihistamine) and anticholinergic used as an antipruritic. It is nowadays scarcely used in the first line relief of allergies due to the anticholinergic side effect of somnolence but does have some limited use through topical application in the relief of insect bites and related itching (pruritus).

Originator

Sources: Arzneimittel-Forschung, Volume 7, Pages 237-52, Journal, 1957

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Calmogel

Approved Use

Unknown
Doses

Doses

DosePopulationAdverse events​
1 % single, topical
Recommended
Dose: 1 %
Route: topical
Route: single
Dose: 1 %
Sources: Page: p.429
unhealthy, 41
n = 41
Health Status: unhealthy
Condition: Dermatisis
Age Group: 41
Sex: F
Population Size: 41
Sources: Page: p.429
Disc. AE: Allergic contact dermatitis...
AEs leading to
discontinuation/dose reduction:
Allergic contact dermatitis
Sources: Page: p.429
72 mg multiple, oral (max)
Studied dose
Dose: 72 mg
Route: oral
Route: multiple
Dose: 72 mg
Sources: Page: p.160
unhealthy
n = 72
Health Status: unhealthy
Condition: Urticaria | sensitization dermatitis|dermatoses
Sex: M+F
Population Size: 72
Sources: Page: p.160
Disc. AE: Weakness generalised...
AEs leading to
discontinuation/dose reduction:
Weakness generalised (1 patient)
Sources: Page: p.160
AEs

AEs

AESignificanceDosePopulation
Allergic contact dermatitis Disc. AE
1 % single, topical
Recommended
Dose: 1 %
Route: topical
Route: single
Dose: 1 %
Sources: Page: p.429
unhealthy, 41
n = 41
Health Status: unhealthy
Condition: Dermatisis
Age Group: 41
Sex: F
Population Size: 41
Sources: Page: p.429
Weakness generalised 1 patient
Disc. AE
72 mg multiple, oral (max)
Studied dose
Dose: 72 mg
Route: oral
Route: multiple
Dose: 72 mg
Sources: Page: p.160
unhealthy
n = 72
Health Status: unhealthy
Condition: Urticaria | sensitization dermatitis|dermatoses
Sex: M+F
Population Size: 72
Sources: Page: p.160
PubMed

PubMed

TitleDatePubMed
Phototoxic and photoprotective effects of topical isothipendyl.
1995 Apr
Spectrophotometric determination of molybdenum(VI) using isothipendyl hydrochloride and pipazethate hydrochloride in alloy steels and soil samples.
2001 Sep
Spectrophotometric studies on the investigation of chromium in environmental samples.
2003 Jan
Bis[N,N-dimethyl-1-(10H-pyrido[3,2-b][1,4]benzothia-zin-10-yl)propan-2-aminium] tetrakis-(thio-cyanato-κN)cobaltate(II).
2010 Jun 16
Patents

Patents

Sample Use Guides

The dosage of isothipendyl in children was 6 to 8 mg. daily given as a syrup containing 2 mg. per teaspoonful. In adults the dosage varied from one 4 mg. tablet thrice daily to two 12 mg. sustained-action tablets thrice daily
Route of Administration: Oral
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Fri Dec 15 18:44:56 GMT 2023
Edited
by admin
on Fri Dec 15 18:44:56 GMT 2023
Record UNII
WVZ7K9P0JY
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ISOTHIPENDYL
INN   MI   WHO-DD  
INN  
Official Name English
D-201
Code English
UDANTOL
Brand Name English
ODANTOL
Brand Name English
(±)-ISOTHIPENDYL
Common Name English
ISOTHIPENDYL [MI]
Common Name English
isothipendyl [INN]
Common Name English
DIMETHYLAMINOISOPROPYLAZAPHENOTHIAZINE
Systematic Name English
10H-PYRIDO(3,2-B)(1,4)BENZOTHIAZINE-10-ETHANAMINE, N,N,.ALPHA.-TRIMETHYL-
Systematic Name English
10-(2-DIMETHYLAMINOPROPYL)-10H-PYRIDO(3,2-B)(1,4)BENZOTHIAZINE
Systematic Name English
10H-PYRIDO(3,2-B)(1,4)BENZOTHIAZINE, 10-(2-(DIMETHYLAMINO)PROPYL)-
Systematic Name English
ACTAPRONT
Brand Name English
Isothipendyl [WHO-DD]
Common Name English
N-DIMETHYLAMINOISOPROPYLTHIOPHENYLPYRIDYLAMINE
Systematic Name English
AY-56012
Code English
Classification Tree Code System Code
WHO-ATC D04AA22
Created by admin on Fri Dec 15 18:44:57 GMT 2023 , Edited by admin on Fri Dec 15 18:44:57 GMT 2023
WHO-VATC QD04AA22
Created by admin on Fri Dec 15 18:44:57 GMT 2023 , Edited by admin on Fri Dec 15 18:44:57 GMT 2023
WHO-ATC R06AD09
Created by admin on Fri Dec 15 18:44:57 GMT 2023 , Edited by admin on Fri Dec 15 18:44:57 GMT 2023
WHO-VATC QR06AD09
Created by admin on Fri Dec 15 18:44:57 GMT 2023 , Edited by admin on Fri Dec 15 18:44:57 GMT 2023
Code System Code Type Description
PUBCHEM
3781
Created by admin on Fri Dec 15 18:44:57 GMT 2023 , Edited by admin on Fri Dec 15 18:44:57 GMT 2023
PRIMARY
ECHA (EC/EINECS)
207-578-5
Created by admin on Fri Dec 15 18:44:57 GMT 2023 , Edited by admin on Fri Dec 15 18:44:57 GMT 2023
PRIMARY
ChEMBL
CHEMBL2111066
Created by admin on Fri Dec 15 18:44:57 GMT 2023 , Edited by admin on Fri Dec 15 18:44:57 GMT 2023
PRIMARY
SMS_ID
100000082856
Created by admin on Fri Dec 15 18:44:57 GMT 2023 , Edited by admin on Fri Dec 15 18:44:57 GMT 2023
PRIMARY
NCI_THESAURUS
C170083
Created by admin on Fri Dec 15 18:44:57 GMT 2023 , Edited by admin on Fri Dec 15 18:44:57 GMT 2023
PRIMARY
RXCUI
28012
Created by admin on Fri Dec 15 18:44:57 GMT 2023 , Edited by admin on Fri Dec 15 18:44:57 GMT 2023
PRIMARY RxNorm
MESH
C008214
Created by admin on Fri Dec 15 18:44:57 GMT 2023 , Edited by admin on Fri Dec 15 18:44:57 GMT 2023
PRIMARY
WIKIPEDIA
Isothipendyl
Created by admin on Fri Dec 15 18:44:57 GMT 2023 , Edited by admin on Fri Dec 15 18:44:57 GMT 2023
PRIMARY
EPA CompTox
DTXSID5048267
Created by admin on Fri Dec 15 18:44:57 GMT 2023 , Edited by admin on Fri Dec 15 18:44:57 GMT 2023
PRIMARY
FDA UNII
WVZ7K9P0JY
Created by admin on Fri Dec 15 18:44:57 GMT 2023 , Edited by admin on Fri Dec 15 18:44:57 GMT 2023
PRIMARY
INN
689
Created by admin on Fri Dec 15 18:44:57 GMT 2023 , Edited by admin on Fri Dec 15 18:44:57 GMT 2023
PRIMARY
MERCK INDEX
m6543
Created by admin on Fri Dec 15 18:44:57 GMT 2023 , Edited by admin on Fri Dec 15 18:44:57 GMT 2023
PRIMARY Merck Index
CAS
482-15-5
Created by admin on Fri Dec 15 18:44:57 GMT 2023 , Edited by admin on Fri Dec 15 18:44:57 GMT 2023
PRIMARY
DRUG BANK
DB08802
Created by admin on Fri Dec 15 18:44:57 GMT 2023 , Edited by admin on Fri Dec 15 18:44:57 GMT 2023
PRIMARY
DRUG CENTRAL
1507
Created by admin on Fri Dec 15 18:44:57 GMT 2023 , Edited by admin on Fri Dec 15 18:44:57 GMT 2023
PRIMARY
EVMPD
SUB08339MIG
Created by admin on Fri Dec 15 18:44:57 GMT 2023 , Edited by admin on Fri Dec 15 18:44:57 GMT 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
Related Record Type Details
ACTIVE MOIETY